CasNo.23141-25-5,1,2,7,8,13,13bβ,14,14aα-Octahydro-1β-vinyl-2α-(β-D-glucopyranosyloxy)-5H-indolo[2,3-a]pyrano[3,4-g]quinolizine-5-one,1,2,7,8,13,13bβ,14,14aα-Octahydro-1β-vinyl-2α-(β-D-glucopyranosyloxy)-5H-indolo[2,3-a]pyrano[3,4-g]quinolizine-5-one(23141-25-5) Suppliers

0	Negotiable

Min.Order :0
Purity: >98%

Keywords

1,2,7,8,13,13bβ,14,14aα-Octahydro-1β-vinyl-2α-(β-D-glucopyranosyloxy)-5H-indolo[2,3-a]pyrano[3,4-g]quinolizine-5-one

Quick Details

Appearance:Powder
Application:anti-inflammatory
PackAge:1 mg
ProductionCapacity:
Storage:
Transportation:

Superiority:

We provide customized and high-quality 1,2,7,8,13,13bβ,14,14aα-Octahydro-1β-vinyl-2α-(β-D-glucopyranosyloxy)-5H-indolo[2,3-a]pyrano[3,4-g]quinolizine-5-one product for your project.

Details:

Strictosamide is a natural alkaloid isolated from the herbs of Nauclea latifolia, it exhibits the activity of anti-inflammatory. In vitro and in vivo, strictosamide has no effection on kidney Na(+),K(+)-ATPase, but in vivo it produces
an increase of Na+,K+-ATPase activity of brain, these findings indicate that
the compound may be related to the induction of α2 isoform of Na+,K+-ATPase.
Furthermore strictosamide has nonsignificant effection on brain, but inhibite the in vitro and in vivo Mg2+-ATPase activity on kidney.